Hot Pursuit     13-Feb-23
Biocon says USFDA issues CRL for biologics license application for Bevacizumab
The U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for the Biologics License Application (BLA) for Bevacizumab filed by partner Viatris (Mylan).
"The U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for the Biologics License Application (BLA) for Bevacizumab filed by our partner Viatris (Mylan). The CRL informs the need for a satisfactory resolution of the observations made during the facility inspection conducted in August, 2022. We have submitted a comprehensive Corrective and Preventive Action (CAPA) plan, to the agency and are confident of addressing the observations within the stipulated timeframe. The CRL did not identify any outstanding scientific issues with the dossier," - Biocon Biologics spokesperson said.

Biocon is an innovation-led, global biopharmaceutical company committed to enhancing affordable access to complex therapies for chronic conditions like diabetes, cancer and autoimmune diseases.

The company had reported a net profit (before exceptional items) of Rs 168 crore in Q2 FY23, down by 10% from Rs 188 crore in Q2 FY22. Revenue from operations increased by 26% YoY to Rs 2,320 crore during the quarter.

The Biocon scrip fell 0.29% to settle trade at Rs 242.45 on Friday, 10 February 2023.

Previous News
  Indices trade with decent gains; realty shares rallied for 5th day
 ( Market Commentary - Mid-Session 17-May-24   12:40 )
  Biocon slips after CFO resigns
 ( Hot Pursuit - 15-Mar-24   11:08 )
  Biocon reports consolidated net profit of Rs 660.00 crore in the December 2023 quarter
 ( Results - Announcements 09-Feb-24   07:41 )
  Biocon CFO resigns
 ( Corporate News - 08-Feb-24   19:43 )
  Biocon AGM scheduled
 ( Corporate News - 17-May-24   13:47 )
  Biocon Biologics completes acquisition of Viatris' global biosimilars business
 ( Corporate News - 29-Nov-22   19:13 )
  Biocon announces resignation of senior management
 ( Corporate News - 08-Feb-24   19:49 )
  Biocon to discuss results
 ( Corporate News - 20-Apr-23   11:22 )
  Biocon Ltd soars 0.15%, up for fifth straight session
 ( Hot Pursuit - 20-Jul-23   13:00 )
  Biocon to hold board meeting
 ( Corporate News - 02-Jul-22   09:59 )
  Biocon's Malaysian facility completes USFDA inspection
 ( Corporate News - 25-Sep-21   13:11 )
Other Stories
  RVNL gains on emerging as L-1 bidder for Rs 133-cr railway project
  03-Jul-24   15:38
  Cholamandalam Financial Holdings Ltd leads losers in 'A' group
  03-Jul-24   15:00
  Sakuma Exports Ltd leads losers in 'B' group
  03-Jul-24   14:45
  NTPC power generation climbs 9.5% YoY in Q1
  03-Jul-24   14:41
  Volumes soar at MMTC Ltd counter
  03-Jul-24   14:30
  Oil and Gas shares fall
  03-Jul-24   14:00
  Real Estate stocks edge lower
  03-Jul-24   14:00
  Energy stocks edge lower
  03-Jul-24   14:00
  Sundaram-Clayton gains after board OKs to raise funds upto Rs 400 cr
  03-Jul-24   13:38
  JSW Infra's subsidiary concession agreement V.O. Chidambaranar Port Authority
  03-Jul-24   13:34
Back Top